Nontuberculous mycobacteria infections in patients receiving immunosuppressive agents Source: Eur Respir Monogr 2018; 81: 238-253 Year: 2018
Adverse events during treatment of nontuberculous mycobacterial lung disease: do they really matter? Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018
Opportunist mycobacterial lung disease - which drug combination is more effective? Source: Breathe 2009; 6: 67-69 Year: 2009
Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions Year: 2011
Non-tuberculous mycobacteria: how to treat these difficult infections Source: International Congress 2018 – State of the art session: Respiratory infections Year: 2018
Treatment of pulmonary NTM infection: can it be done? Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge Year: 2007
Nontuberculous mycobacteriosis - from diagnosis to therapy Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005
A study of patients with pulmonary tuberculosis and confirmed coexistence of nontuberculous mycobacteria during treatment: Does the use of the additional acid-fast bacilli sputum test lead to shorter hospitalization? Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014
Bedaquiline in the treatment of multi-drug resistant non-tuberculous mycobacteria soft tissue infections: a case series Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021
Non-tuberculous infections in patients with TNF-alpha-antagonist treatment Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response Source: Eur Respir J 2004; 23: 741-746 Year: 2004
Pharmacokinetics of drugs for non tuberculous mycobacterial lung infections Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis Source: Eur Respir J 2010; 35: 338-342 Year: 2010
Non-tuberculous mycobacteria effect in the diagnosis of latent tuberculosis infection in children Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010
Is delamanid a potential agent in the treatment of diseases caused by Mycobacterium avium-intracellulare? Source: Eur Respir J 2016; 48: 1803-1804 Year: 2016
Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis? Source: Eur Respir J 2010; 35: 606-613 Year: 2010
The effectiveness of pulmonary TB treatment in patients with organic liver diseases, depending on the way of administration of anti-TB drugs Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Pathogenicity of NTM: new developments Source: Annual Congress 2007 - Nontuberculous mycobacteria (NTM): a slow-growing challenge Year: 2007
Non-tuberculous infections in patients with anti-TNF treatment Source: Annual Congress 2010 - Treatment options for asthma Year: 2010
Evaluation of drug induced liver injury due to anti tuberculous drugs in directly observed daily therapy Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016